Sclerotherapy in Treatment of Venous Diseases: A Comprehensive Review of Best Practices While Using Compounded and FDA-Approved Agents

Sclerotherapy in Treatment of Venous Diseases: A Comprehensive Review of Best Practices While Using Compounded and FDA-Approved Agents

On-Demand Webcast

Nick Morrison, MD, FACPH, FACS, RPHS
President, International Union of Phlebology
Co-Founder and Medical Director
Morrison Vein Institute
Tempe, Arizona

Karla L. Palmer, JD
Director, Hyman, Phelps & McNamara, P.C.
Washington D.C.

Gilly Munavalli, MD, MHS, FACMS
Assistant Clinical Professor
Wake Forest Dermatology
Wake Forest, North Carolina
Medical Director
Dermatology, Laser, and Vein
Specialists of the Carolinas
Charlotte, North Carolina

Intended Learners

This activity is designed for vascular surgeons, general surgeons, interventional cardiologists, interventional radiologists, cardiothoracic surgeons, phlebologists, wound care specialists, podiatrists, dermatologists, plastic surgeons, cosmetic surgeons, nurses and technologists who treat chronic venous insufficiency.

Learning Objectives

After completing this activity, participants should be able to:

  • Identify when to use sclerotherapy in a patient with varicose veins, or related chronic venous insufficiency.
  • Identify the economic, safety and legal factors when choosing a compounded sclerosant vs. FDA approved sclerosant.
  • Describe risk factors associated with compounded sclerosants.
Activity Overview

This on-demand webcast is available with synchronized slides and video.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at, participants may immediately print their documentation of credit.

Release Date: June 13, 2017
Expiration Date: June 13, 2019
Estimated time to complete: 1.0 hour

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested (please download here) for video programs. A PDF reader is required for print publications. Please direct technical questions to


  In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This continuing nursing education activity awards 1.00 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.00 contact hours.

Independent Clinical Reviewer: Robert S. Dieter, MD, RVT, FACC, Associate Professor, Vascular & Endovascular Medicine and Interventional Cardiology Loyola University Medical Center, Maywood, IL

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Continuing Podiatric Education

North American Center for Continuing Medical Education, LCC (NACCME) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. NACCME has approved this activity for a maximum of 1.0 continuing education contact hour.

Planning Committee

The planning committee comprises Robert Dieter, MD, RVT, FACC, Nick Morrison, MD, FACPH, FACS, RPHS, Gilly Munavalli, MD, MHS, FACMS, Karla L. Palmer, JD, Susie Seaman, NP; and MaryEllen Fama, Jennifer Ilcyn, Randy Robbin, John Savage, Colleen Waters, and Stephanie Weiss, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Dr. Dieter has disclosed no relevant financial relationships with any commercial interests.

Dr. Morrison: Consultant—Medtronic, Merz.; Educational Grant—Medi; Research Grant—Medtronic; Speakers’ Bureau—Medi

Dr. Munavalli: Speakers’ Bureau—Merz

Ms. Palmer has disclosed no relevant financial relationships with any commercial interests.

Ms. Seaman: Promotional Speakers’ Bureau—Smith & Nephew; Scientific Advisor—Smith & Nephew 

Mrs. Fama, Ms. Ilcyn, Mr. Robbin, Mr. Savage, Ms. Waters, and Ms. Weiss have disclosed no relevant financial relationships with any commercial interests. 

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed that the off-label/unapproved use of polidocanol injection and sodium tetradecyl sulfate injection for the treatment of chronic venous insufficiency will be discussed in the presentations. 

Grant Support

Supported by an educational grant from AngioDynamics Inc.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2017 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.